首页 > 最新文献

Indian Journal of Gastroenterology最新文献

英文 中文
Reply: Population muscle mass and performance indices. 答复:群体肌肉质量和表现指数
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-15 DOI: 10.1007/s12664-024-01667-2
Sandeep Singh Sidhu, Kavita Saggar, Omesh Goyal, Harsh Kishore, Samarth Singh Sidhu
{"title":"Reply: Population muscle mass and performance indices.","authors":"Sandeep Singh Sidhu, Kavita Saggar, Omesh Goyal, Harsh Kishore, Samarth Singh Sidhu","doi":"10.1007/s12664-024-01667-2","DOIUrl":"https://doi.org/10.1007/s12664-024-01667-2","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic interventions in pancreatic strictures and stones-A structured approach. 胰腺狭窄和结石的内窥镜干预--一种结构化方法。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-15 DOI: 10.1007/s12664-024-01644-9
Manu Tandan, Partha Pal, Nitin Jagtap, D Nageshwar Reddy

Chronic pancreatitis (CP) is an irreversible disease of varied etiology characterized by destruction of pancreatic tissue and loss of both exocrine and endocrine function. Pain is the dominant and most common presenting symptom. The common cause for pain in CP is ductal hypertension due to obstruction of the flow of pancreatic juice in the main pancreatic duct either due to stones or stricture or a combination of both. With advances in technology and techniques, endoscopic retrograde cholangiography (ERCP) and stenting should be the first line of therapy for strictures of the main pancreatic duct (MPD). Small calculi in the MPD can be extracted by ERCP and balloon trawl. Extracorporeal shockwave lithotripsy (ESWL) remains the standard of care for large pancreatic calculi and aims to fragment the stones 3 mm or less that can easily be extracted by a subsequent ERCP. Single operator pancreatoscopy with intraductal lithotripsy is a technique in evolution and can be tried when ESWL is not available or is unsuccessful in producing stone fragmentation.

慢性胰腺炎(CP)是一种病因多样的不可逆疾病,其特点是胰腺组织遭到破坏,外分泌和内分泌功能丧失。疼痛是主要和最常见的症状。CP 疼痛的常见原因是主胰管结石或狭窄或两者兼而有之导致胰液流动受阻引起的胰管高压。随着科技和技术的进步,内镜逆行胰胆管造影术(ERCP)和支架植入术应成为治疗主胰管(MPD)狭窄的首选方法。 主胰管中的小结石可通过ERCP和球囊牵引器取出。体外冲击波碎石术(ESWL)仍是治疗大块胰腺结石的标准方法,其目的是将 3 毫米或更小的结石击碎,以便在随后的ERCP中轻松取出。单人操作胰腺镜加导管内碎石术是一种正在发展中的技术,在无法使用 ESWL 或无法成功碎石时可以尝试使用。
{"title":"Endoscopic interventions in pancreatic strictures and stones-A structured approach.","authors":"Manu Tandan, Partha Pal, Nitin Jagtap, D Nageshwar Reddy","doi":"10.1007/s12664-024-01644-9","DOIUrl":"https://doi.org/10.1007/s12664-024-01644-9","url":null,"abstract":"<p><p>Chronic pancreatitis (CP) is an irreversible disease of varied etiology characterized by destruction of pancreatic tissue and loss of both exocrine and endocrine function. Pain is the dominant and most common presenting symptom. The common cause for pain in CP is ductal hypertension due to obstruction of the flow of pancreatic juice in the main pancreatic duct either due to stones or stricture or a combination of both. With advances in technology and techniques, endoscopic retrograde cholangiography (ERCP) and stenting should be the first line of therapy for strictures of the main pancreatic duct (MPD). Small calculi in the MPD can be extracted by ERCP and balloon trawl. Extracorporeal shockwave lithotripsy (ESWL) remains the standard of care for large pancreatic calculi and aims to fragment the stones 3 mm or less that can easily be extracted by a subsequent ERCP. Single operator pancreatoscopy with intraductal lithotripsy is a technique in evolution and can be tried when ESWL is not available or is unsuccessful in producing stone fragmentation.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Per-oral endoscopic septotomy in a pacemaker-dependent patient with Zenker's diverticulum using a novel bipolar device. 使用新型双极装置为一名有起搏器依赖症的 Zenker 胃憩室患者进行口腔内窥镜隔膜切除术。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-10 DOI: 10.1007/s12664-024-01658-3
Zaheer Nabi, Jahangeer Basha, Santhosh Darisetty, D Nageshwar Reddy
{"title":"Per-oral endoscopic septotomy in a pacemaker-dependent patient with Zenker's diverticulum using a novel bipolar device.","authors":"Zaheer Nabi, Jahangeer Basha, Santhosh Darisetty, D Nageshwar Reddy","doi":"10.1007/s12664-024-01658-3","DOIUrl":"https://doi.org/10.1007/s12664-024-01658-3","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of etiology and outcomes of acute liver failure in India-A multicentre study from tertiary centres. 印度急性肝衰竭的病因和结果现状--来自三级中心的多中心研究。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-07 DOI: 10.1007/s12664-024-01634-x
Akash Roy, Karan Kumar, Madhumita Premkumar, Amarthya Sree, Anand Gupta, Mithun Sharma, Manasa Alla, Sowmya Iyengar, Shantan Venishetty, Uday C Ghoshal, Mahesh Goenka, Padaki Nagaraja Rao, Vivek Anand Saraswat, Nageshwar Duvvur Reddy, Anand V Kulkarni, Rajender K Reddy

Background and aims: Acute liver failure (ALF) is a medical emergency and liver transplantation (LT) may be required as definitive therapy. The etiology varies across geographical locations and is mostly viral dominant in India. We aimed at evaluating the spectrum, impact of interventions (plasma exchange [PLEx], continuous renal replacement therapy [CRRT]) and outcomes of ALF in India in recent times.

Methods: A multicentre retrospective study across four major tertiary care centres.

Results: As many as 183 ALF patients (median age, 23 years; females, 43.1%; model for end-stage liver disease [MELD], 32.7) from January 2021 to December 2023 were included. Nineteen per cent had infection and 40.4% of patients satisfied King's College criteria (KCC) at admission. Most common cause for ALF was hepatitis A virus (HAV) (44.2%) followed by rodenticide poisoning (10.3%). Approximately 35% of patients each received either PLEx or CRRT. The 7, 14 and 21-day transplant-free survival probability was 65.5%, 60.1%, and 57.3%, respectively. Only 3.8% of patients underwent liver transplantation. On multivariable Cox regression analysis, hemoglobin (HR, 0.74 [0.63-0.87]), lactate (HR, 1.14 [1.03-1.26]), advanced hepatic encephalopathy (HE) (HR, 4.87 [1.89-12.5]) and fulfilling KCC [HR, 10.04 [4.57-22.06]) at admission were the independent predictors of mortality. A model including KCC + lactate + HE ≥ 3 with or without hemoglobin had an AUROC of 0.81-0.84 to predict mortality. In those who underwent PLEx, advanced HE (HR, 4.13 [1.75-9.7]), procalcitonin (HR, 1.18 [1.07-1.30]) and KCC (HR, 4.6 [1.6-13.1), while for those who received CRRT, lactate (HR, 1.37 [1.22-1.54]) and KCC (HR, 6.4 [2.5-15.8]) independently predicted mortality.

Conclusions: Hepatitis A virus is currently the most common cause for ALF in India, emphasizing the need for universal vaccination programmes. Spontaneous survival in tertiary care centres is 57%. LT rates were low.

背景和目的:急性肝衰竭(ALF)是一种医疗急症,可能需要肝移植(LT)作为最终治疗手段。不同地区的病因各不相同,在印度主要以病毒为主。我们的目的是评估近期印度 ALF 的病谱、干预措施(血浆置换 [PLEx]、持续肾脏替代疗法 [CRRT])的影响和结果:方法:在四个主要的三级医疗中心进行多中心回顾性研究:研究纳入了2021年1月至2023年12月期间的183名ALF患者(中位年龄23岁;女性占43.1%;终末期肝病模型[MELD]32.7)。19%的患者有感染,40.4%的患者入院时符合国王学院标准(KCC)。ALF最常见的病因是甲型肝炎病毒(HAV)(44.2%),其次是杀鼠剂中毒(10.3%)。约 35% 的患者分别接受了 PLEx 或 CRRT 治疗。7天、14天和21天无移植生存概率分别为65.5%、60.1%和57.3%。只有3.8%的患者接受了肝移植。在多变量考克斯回归分析中,入院时的血红蛋白(HR,0.74 [0.63-0.87])、乳酸(HR,1.14 [1.03-1.26])、晚期肝性脑病(HE)(HR,4.87 [1.89-12.5])和KCC(HR,10.04 [4.57-22.06])是预测死亡率的独立因素。KCC+乳酸+HE≥3(含或不含血红蛋白)模型预测死亡率的AUROC为0.81-0.84。在接受PLEx治疗的患者中,晚期HE(HR,4.13 [1.75-9.7])、降钙素原(HR,1.18 [1.07-1.30])和KCC(HR,4.6 [1.6-13.1])可独立预测死亡率,而在接受CRRT治疗的患者中,乳酸盐(HR,1.37 [1.22-1.54])和KCC(HR,6.4 [2.5-15.8])可独立预测死亡率:结论:甲型肝炎病毒是印度目前最常见的ALF病因,因此需要普及疫苗接种计划。三级医疗中心的自发存活率为 57%。LT率较低。
{"title":"Current status of etiology and outcomes of acute liver failure in India-A multicentre study from tertiary centres.","authors":"Akash Roy, Karan Kumar, Madhumita Premkumar, Amarthya Sree, Anand Gupta, Mithun Sharma, Manasa Alla, Sowmya Iyengar, Shantan Venishetty, Uday C Ghoshal, Mahesh Goenka, Padaki Nagaraja Rao, Vivek Anand Saraswat, Nageshwar Duvvur Reddy, Anand V Kulkarni, Rajender K Reddy","doi":"10.1007/s12664-024-01634-x","DOIUrl":"https://doi.org/10.1007/s12664-024-01634-x","url":null,"abstract":"<p><strong>Background and aims: </strong>Acute liver failure (ALF) is a medical emergency and liver transplantation (LT) may be required as definitive therapy. The etiology varies across geographical locations and is mostly viral dominant in India. We aimed at evaluating the spectrum, impact of interventions (plasma exchange [PLEx], continuous renal replacement therapy [CRRT]) and outcomes of ALF in India in recent times.</p><p><strong>Methods: </strong>A multicentre retrospective study across four major tertiary care centres.</p><p><strong>Results: </strong>As many as 183 ALF patients (median age, 23 years; females, 43.1%; model for end-stage liver disease [MELD], 32.7) from January 2021 to December 2023 were included. Nineteen per cent had infection and 40.4% of patients satisfied King's College criteria (KCC) at admission. Most common cause for ALF was hepatitis A virus (HAV) (44.2%) followed by rodenticide poisoning (10.3%). Approximately 35% of patients each received either PLEx or CRRT. The 7, 14 and 21-day transplant-free survival probability was 65.5%, 60.1%, and 57.3%, respectively. Only 3.8% of patients underwent liver transplantation. On multivariable Cox regression analysis, hemoglobin (HR, 0.74 [0.63-0.87]), lactate (HR, 1.14 [1.03-1.26]), advanced hepatic encephalopathy (HE) (HR, 4.87 [1.89-12.5]) and fulfilling KCC [HR, 10.04 [4.57-22.06]) at admission were the independent predictors of mortality. A model including KCC + lactate + HE ≥ 3 with or without hemoglobin had an AUROC of 0.81-0.84 to predict mortality. In those who underwent PLEx, advanced HE (HR, 4.13 [1.75-9.7]), procalcitonin (HR, 1.18 [1.07-1.30]) and KCC (HR, 4.6 [1.6-13.1), while for those who received CRRT, lactate (HR, 1.37 [1.22-1.54]) and KCC (HR, 6.4 [2.5-15.8]) independently predicted mortality.</p><p><strong>Conclusions: </strong>Hepatitis A virus is currently the most common cause for ALF in India, emphasizing the need for universal vaccination programmes. Spontaneous survival in tertiary care centres is 57%. LT rates were low.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of dominant stricture and disease duration on prognosis in primary sclerosing cholangitis. 显性狭窄和病程对原发性硬化性胆管炎预后的影响
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-07 DOI: 10.1007/s12664-024-01660-9
Muhammed Bahaddin Durak
{"title":"Effect of dominant stricture and disease duration on prognosis in primary sclerosing cholangitis.","authors":"Muhammed Bahaddin Durak","doi":"10.1007/s12664-024-01660-9","DOIUrl":"https://doi.org/10.1007/s12664-024-01660-9","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The etiological profile of chronic organic non-bloody diarrhea in India: Emergence of inflammatory bowel disease as a dominant cause. 印度慢性器质性非血性腹泻的病因概况:炎症性肠病成为主要病因。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-02 DOI: 10.1007/s12664-024-01649-4
Prachi Daga, Amarender Singh Puri, Lipika Lipi, Sumit Bhatia, Randhir Sud

Background: Chronic non-bloody diarrhea may be attributed either to functional or organic diseases. The latter category may present with malabsorption syndrome if there is extensive involvement of the small bowel, whereas diseases of the large bowel may only present with diarrhea sans malabsorption. Indian data has predominantly focussed on the etiological spectrum of malabsorption syndrome in adults. The primary aim of the current study was to evaluate etiological spectrum of chronic organic non-bloody diarrhea in India.

Methods: This prospective observational study was done at a tertiary care hospital in North India. Patients ≥ 18 years presenting with chronic non-bloody diarrhea of > 4 weeks duration were enrolled in the study after exclusion of patients with IBS and anal incontinence.

Results: During the study period of 12 months, 100 patients with chronic organic non-bloody diarrhea were evaluated. A definite etiological diagnosis was made in 97 patients (97%). The mean age of the patients was 48 ± 16.7 years (58% males). The median duration of diarrhea was 5.5 months (interquartile range [IQR] 3.5, 11). Inflammatory bowel disease (IBD) accounted for 45% of the cases making it the predominant cause for organic diarrhea. GI infections and adult-onset celiac disease accounted for 18% and 9% of the cases, respectively. Pancreatic disease, benign or neoplastic, accounted for 6% of the total cases. Notably, gastrointestinal (GI) malignancies manifesting as chronic non-bloody diarrhea were diagnosed in 5% of the patients.

Conclusion: Our data suggests a paradigm shift in the etiological spectrum of chronic organic non-bloody diarrhea in India with the emergence of IBD as the predominant cause displacing GI infections.

背景:慢性非血性腹泻可归因于功能性疾病或器质性疾病。如果小肠广泛受累,后一类疾病可能会表现为吸收不良综合征,而大肠疾病可能只表现为腹泻而无吸收不良。印度的数据主要集中在成人吸收不良综合征的病因学方面。本研究的主要目的是评估印度慢性器质性非血性腹泻的病因谱:这项前瞻性观察研究在印度北部的一家三级医院进行。在排除肠易激综合征(IBS)和肛门失禁患者后,将病程超过 4 周、年龄≥ 18 岁的慢性非带血性腹泻患者纳入研究:在12个月的研究期间,对100名慢性器质性非带血性腹泻患者进行了评估。97名患者(97%)得到了明确的病因诊断。患者的平均年龄为 48±16.7 岁(58% 为男性)。腹泻持续时间的中位数为 5.5 个月(四分位数间距 [IQR] 3.5 - 11)。炎症性肠病(IBD)占病例总数的 45%,是引起器质性腹泻的主要原因。消化道感染和成人腹腔疾病分别占 18% 和 9%。良性或肿瘤性胰腺疾病占病例总数的 6%。值得注意的是,5%的患者被诊断出表现为慢性非血性腹泻的胃肠道(GI)恶性肿瘤:我们的数据表明,印度慢性器质性非血性腹泻的病因发生了转变,IBD 取代消化道感染成为主要病因。
{"title":"The etiological profile of chronic organic non-bloody diarrhea in India: Emergence of inflammatory bowel disease as a dominant cause.","authors":"Prachi Daga, Amarender Singh Puri, Lipika Lipi, Sumit Bhatia, Randhir Sud","doi":"10.1007/s12664-024-01649-4","DOIUrl":"https://doi.org/10.1007/s12664-024-01649-4","url":null,"abstract":"<p><strong>Background: </strong>Chronic non-bloody diarrhea may be attributed either to functional or organic diseases. The latter category may present with malabsorption syndrome if there is extensive involvement of the small bowel, whereas diseases of the large bowel may only present with diarrhea sans malabsorption. Indian data has predominantly focussed on the etiological spectrum of malabsorption syndrome in adults. The primary aim of the current study was to evaluate etiological spectrum of chronic organic non-bloody diarrhea in India.</p><p><strong>Methods: </strong>This prospective observational study was done at a tertiary care hospital in North India. Patients ≥ 18 years presenting with chronic non-bloody diarrhea of > 4 weeks duration were enrolled in the study after exclusion of patients with IBS and anal incontinence.</p><p><strong>Results: </strong>During the study period of 12 months, 100 patients with chronic organic non-bloody diarrhea were evaluated. A definite etiological diagnosis was made in 97 patients (97%). The mean age of the patients was 48 ± 16.7 years (58% males). The median duration of diarrhea was 5.5 months (interquartile range [IQR] 3.5, 11). Inflammatory bowel disease (IBD) accounted for 45% of the cases making it the predominant cause for organic diarrhea. GI infections and adult-onset celiac disease accounted for 18% and 9% of the cases, respectively. Pancreatic disease, benign or neoplastic, accounted for 6% of the total cases. Notably, gastrointestinal (GI) malignancies manifesting as chronic non-bloody diarrhea were diagnosed in 5% of the patients.</p><p><strong>Conclusion: </strong>Our data suggests a paradigm shift in the etiological spectrum of chronic organic non-bloody diarrhea in India with the emergence of IBD as the predominant cause displacing GI infections.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141874715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of artificial intelligence in biliary tract cancers. 人工智能在胆道癌症中的应用。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-03-01 DOI: 10.1007/s12664-024-01518-0
Pankaj Gupta, Soumen Basu, Chetan Arora

Biliary tract cancers are malignant neoplasms arising from bile duct epithelial cells. They include cholangiocarcinomas and gallbladder cancer. Gallbladder cancer has a marked geographical preference and is one of the most common cancers in women in northern India. Biliary tract cancers are usually diagnosed at an advanced, unresectable stage. Hence, the prognosis is extremely dismal. The five-year survival rate in advanced gallbladder cancer is < 5%. Hence, early detection and radical surgery are critical to improving biliary tract cancer prognoses. Radiological imaging plays an essential role in diagnosing and managing biliary tract cancers. However, the diagnosis is challenging because the biliary tract is affected by many diseases that may have radiological appearances similar to cancer. Artificial intelligence (AI) can improve radiologists' performance in various tasks. Deep learning (DL)-based approaches are increasingly incorporated into medical imaging to improve diagnostic performance. This paper reviews the AI-based strategies in biliary tract cancers to improve the diagnosis and prognosis.

胆道癌是由胆管上皮细胞引起的恶性肿瘤。它们包括胆管癌和胆囊癌。胆囊癌有明显的地域偏好,是印度北部妇女最常见的癌症之一。胆道癌通常在晚期诊断出来,无法切除。因此,预后极差。晚期胆囊癌的五年生存率为
{"title":"Applications of artificial intelligence in biliary tract cancers.","authors":"Pankaj Gupta, Soumen Basu, Chetan Arora","doi":"10.1007/s12664-024-01518-0","DOIUrl":"10.1007/s12664-024-01518-0","url":null,"abstract":"<p><p>Biliary tract cancers are malignant neoplasms arising from bile duct epithelial cells. They include cholangiocarcinomas and gallbladder cancer. Gallbladder cancer has a marked geographical preference and is one of the most common cancers in women in northern India. Biliary tract cancers are usually diagnosed at an advanced, unresectable stage. Hence, the prognosis is extremely dismal. The five-year survival rate in advanced gallbladder cancer is < 5%. Hence, early detection and radical surgery are critical to improving biliary tract cancer prognoses. Radiological imaging plays an essential role in diagnosing and managing biliary tract cancers. However, the diagnosis is challenging because the biliary tract is affected by many diseases that may have radiological appearances similar to cancer. Artificial intelligence (AI) can improve radiologists' performance in various tasks. Deep learning (DL)-based approaches are increasingly incorporated into medical imaging to improve diagnostic performance. This paper reviews the AI-based strategies in biliary tract cancers to improve the diagnosis and prognosis.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139996136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications. 肝硬化患者的肌少症:揭示肝病严重程度及并发症的发生率和关系。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-06-07 DOI: 10.1007/s12664-024-01550-0
Tahir Majeed, Brij Sharma, Rajesh Sharma, Vishal Bodh, Ashish Chauhan, Mukesh Surya, Bilal Ahmad Mir, Neetu Sharma, Dikshant Sharma

Background and objectives: Sarcopenia in cirrhosis is associated with poor survival and adverse pre and post-transplant outcomes. The study aimed at determining the prevalence of sarcopenia and its association with the severity, complications and etiology of liver disease.

Methods: As many as 416 cirrhotic patients who met the inclusion criteria underwent muscle strength testing using a dynamometer. As many as 109 probable sarcopenia patients underwent computed tomography (CT) scan to measure skeletal muscle index (SMI) at the L3 vertebral level and gait-speed testing. The gender-specific cut-offs used to define sarcopenia were an SMI of 36.54 cm2/m2 in males and 30.21 cm2/m2 in females. A gait speed ≤ 0.8 m/s was taken as a cut-off to define severe sarcopenia in both genders.

Results: The mean age was 54.7 ± 9.51 years and male:female ratio was 2.2:1.The mean body mass index (BMI) was 24.2 ± 1.34 kg/m2. Alcohol and non-alcoholic steatohepatitis (NASH) were the two most common etiologies (45.9% and 31.2%). The proportion of patients belonging to Child-Pugh class A, B and C was 26.6%, 48.6% and 24.8%, respectively. Forty out of 109 (36.7%) patients had a model for end-stage liver disease (MELD) > 14. Ascites, upper gastrointestinal bleeding and hepatic encephalopathy (HE) were present in 59 (54.1%), 60 (55.0%) and 24 (22.0%) patients, respectively. The prevalence of probable sarcopenia, sarcopenia and severe sarcopenia was found to be 26.20%, 10.09% and 6.73%, respectively. Sarcopenia and severe sarcopenia were associated with Child-Pugh class (p < 0.001, p < 0.001), MELD (p = 0.007, 0.002), upper gastrointestinal bleed (p = 0.007, 0.004), ascites (p = 0.038, 0.025) and HE (0.001, < 0.001).

Conclusion: The prevalence of sarcopenia and severe sarcopenia was found to be 10.09% and 6.73%, respectively. Sarcopenia and severe sarcopenia had a significant association with the severity and complications of cirrhosis. However, no association was observed with etiology of liver disease.

背景和目的:肝硬化患者的肌肉疏松症与存活率低以及移植前后的不良预后有关。本研究旨在确定肌肉疏松症的患病率及其与肝病的严重程度、并发症和病因的关系:方法:多达 416 名符合纳入标准的肝硬化患者使用测力计进行了肌力测试。多达 109 名可能患有肌肉疏松症的患者接受了计算机断层扫描(CT),以测量 L3 椎骨水平的骨骼肌指数(SMI)和步速测试。界定 "肌肉疏松症 "的性别临界值为:男性的骨骼肌指数为 36.54 cm2/m2,女性为 30.21 cm2/m2。步速≤0.8米/秒是界定男女严重肌肉疏松症的临界值:平均年龄为 54.7 ± 9.51 岁,男女比例为 2.2:1,平均体重指数(BMI)为 24.2 ± 1.34 kg/m2。酒精和非酒精性脂肪性肝炎(NASH)是两种最常见的病因(45.9% 和 31.2%)。属于 Child-Pugh A、B 和 C 级的患者比例分别为 26.6%、48.6% 和 24.8%。109 名患者中有 40 人(36.7%)的终末期肝病模型(MELD)大于 14。出现腹水、上消化道出血和肝性脑病(HE)的患者分别有 59 人(54.1%)、60 人(55.0%)和 24 人(22.0%)。研究发现,可能出现的肌肉疏松症、肌肉疏松症和严重肌肉疏松症的发病率分别为 26.20%、10.09% 和 6.73%。肌少症和严重肌少症与 Child-Pugh 分级有关(p 结论:肌少症和严重肌少症与 Child-Pugh 分级有关:发现肌肉疏松症和严重肌肉疏松症的发病率分别为 10.09% 和 6.73%。肌少症和严重肌少症与肝硬化的严重程度和并发症有显著关联。但与肝病的病因并无关联。
{"title":"Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.","authors":"Tahir Majeed, Brij Sharma, Rajesh Sharma, Vishal Bodh, Ashish Chauhan, Mukesh Surya, Bilal Ahmad Mir, Neetu Sharma, Dikshant Sharma","doi":"10.1007/s12664-024-01550-0","DOIUrl":"10.1007/s12664-024-01550-0","url":null,"abstract":"<p><strong>Background and objectives: </strong>Sarcopenia in cirrhosis is associated with poor survival and adverse pre and post-transplant outcomes. The study aimed at determining the prevalence of sarcopenia and its association with the severity, complications and etiology of liver disease.</p><p><strong>Methods: </strong>As many as 416 cirrhotic patients who met the inclusion criteria underwent muscle strength testing using a dynamometer. As many as 109 probable sarcopenia patients underwent computed tomography (CT) scan to measure skeletal muscle index (SMI) at the L3 vertebral level and gait-speed testing. The gender-specific cut-offs used to define sarcopenia were an SMI of 36.54 cm<sup>2</sup>/m<sup>2</sup> in males and 30.21 cm<sup>2</sup>/m<sup>2</sup> in females. A gait speed ≤ 0.8 m/s was taken as a cut-off to define severe sarcopenia in both genders.</p><p><strong>Results: </strong>The mean age was 54.7 ± 9.51 years and male:female ratio was 2.2:1.The mean body mass index (BMI) was 24.2 ± 1.34 kg/m<sup>2</sup>. Alcohol and non-alcoholic steatohepatitis (NASH) were the two most common etiologies (45.9% and 31.2%). The proportion of patients belonging to Child-Pugh class A, B and C was 26.6%, 48.6% and 24.8%, respectively. Forty out of 109 (36.7%) patients had a model for end-stage liver disease (MELD) > 14. Ascites, upper gastrointestinal bleeding and hepatic encephalopathy (HE) were present in 59 (54.1%), 60 (55.0%) and 24 (22.0%) patients, respectively. The prevalence of probable sarcopenia, sarcopenia and severe sarcopenia was found to be 26.20%, 10.09% and 6.73%, respectively. Sarcopenia and severe sarcopenia were associated with Child-Pugh class (p < 0.001, p < 0.001), MELD (p = 0.007, 0.002), upper gastrointestinal bleed (p = 0.007, 0.004), ascites (p = 0.038, 0.025) and HE (0.001, < 0.001).</p><p><strong>Conclusion: </strong>The prevalence of sarcopenia and severe sarcopenia was found to be 10.09% and 6.73%, respectively. Sarcopenia and severe sarcopenia had a significant association with the severity and complications of cirrhosis. However, no association was observed with etiology of liver disease.</p>","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of video laryngoscope as a conduit for the passage of endoscope: Expanding the horizon. 使用视频喉镜作为内窥镜的通道:拓展视野。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1007/s12664-023-01402-3
Nipun Saini, Amiya K Barik, Manisha Agrawal, Rajeev Chauhan, Sahaj Rathi
{"title":"Use of video laryngoscope as a conduit for the passage of endoscope: Expanding the horizon.","authors":"Nipun Saini, Amiya K Barik, Manisha Agrawal, Rajeev Chauhan, Sahaj Rathi","doi":"10.1007/s12664-023-01402-3","DOIUrl":"10.1007/s12664-023-01402-3","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9680903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shankhaprakshalana (Dhauti): The missing link. Shankhaprakshalana(Dhauti):缺失的一环。
IF 2 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1007/s12664-024-01650-x
Monika Gautam, Saurabh Kumar, Akshay Anand
{"title":"Shankhaprakshalana (Dhauti): The missing link.","authors":"Monika Gautam, Saurabh Kumar, Akshay Anand","doi":"10.1007/s12664-024-01650-x","DOIUrl":"10.1007/s12664-024-01650-x","url":null,"abstract":"","PeriodicalId":13404,"journal":{"name":"Indian Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141731127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1